计算溶液所需的质量、体积或浓度。
| 活性类型 | 活性值-log(M) | 作用机制 | 期刊 | 参考文献(PubMed IDs) |
|---|
,适用于对基线干扰要求严格的色谱和分析工作流程。
-80℃储存。特低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 2 篇同行评审文献引用。
Cerdulatinib hydrochloride 是一种选择性可逆,具有口服活性、 ATP 竞争性的Syk和JAK的双重抑制剂,它可用于研究自身免疫性疾病和B细胞恶性肿瘤。
激酶实验:Purified Kinase Assays: Potency against purified SYK is determined by fluorescence resonance energy transfer. A broader panel of 270 purified kinases is surveyed in which PRT062070 is tested at a fixed concentration of 300 nM. [33P]-labeled substrate is measured after incubation of purified kinase with peptide substrate and [33P]ATP at the Km concentration for the kinase.
细胞实验:Cell lines (Ramos RA-1, Daudi, Toledo, SU-DHL4 and SU-DHL6) are cultured in RPMI media supplemented with 10% fetal bovine serum. Cells are treated with the indicated concentrations of PRT062070, the SYK-selective inhibitor PRT060318, the pan-JAK inhibitor 1, a 1:1 combination of PRT060318 and JAK inhibitor 1, or vehicle control (0.5% dimethylsulfoxide) for 72 hours. Cell viability assays are performed using CellTiter Glo in 384-well plates. Cells are seeded at a density of 5000 cells per well. (Only for Reference)
Information
Cerdulatinib (PRT-062070, PRT2070) hydrochloride is an oral active, multi-targeted tyrosine kinase inhibitor withIC50of 12 nM/6 nM/8 nM/0.5 nM and 32 nM forJAK1/JAK2/JAK3/TYK2andSyk, respectively. Also inhibits 19 other tested kinases withIC50less than 200 nM.
Targets
TYK2 (Cell-free assay); MST1 (Cell-free assay); ARK5 (Cell-free assay); MLK1 (Cell-free assay); Fms (Cell-free assay);0.5 nM; 4 nM; 4 nM; 5 nM; 5 nM
In vitro
In human whole blood from normal donors, Cerdulatinib affects BCR-mediated B-cell activation by dual inhibition of SYK and JAK. As a dual SYK/JAK inhibitor, Cerdulatinib significantly reduces cell viability in a subset of NHL cell lines, and induces apoptosis in BCR-signaling competent NHL cell lines.
In vivo
In a rat collagen-induced arthritis model, Cerdulatinib (5 mg/kg p.o.) significantly improves inflammatory infiltrate within the synovium and the integrity of the articular cartilage. In addition, Cerdulatinib also blocks BCR-induced B-cell activation and splenomegaly in mice.
Cell Research(from reference)
Cell lines:Ramos RA-1, Daudi, Toledo, SU-DHL4 and SU-DHL6 cells
Concentrations:~15 μM
Incubation Time:72 hours
分类树(Taxonomy Tree)
| 界(kingdom) | 有机化合物 |
|---|---|
| 超类(Superclass) | 有机杂环化合物 |
| 类(Class) | 二嗪烷 |
| 亚类(Subclass) | 哌嗪类 |
| 中间层级节点(Intermediate Tree Nodes) | 暂无 |
| 直接上位类(Direct Parent) | 苯基哌嗪类 |
| 其他上位类(Alternative Parents) | N-芳基哌嗪 嘧啶酰胺类 苯胺和取代苯胺 二烷基芳胺 氨基嘧啶及其衍生物 仲烷基芳胺 有机磺酰胺 有机磺胺类药物 咪唑内酰胺类 乙烯基酰胺 杂芳族化合物 磺酰基 伯羧酸酰胺 氨基酸及其衍生物 氮杂环化合物 有机氧化合物 有机氧化物 盐酸盐 碳氢化合物衍生物 |
| 分子骨架(Molecular Framework) | 芳香族杂单环化合物 |
| 取代基(Substituents) | 氨基酸 - 氨基酸或其衍生物 - 氨基吡啶 - 苯胺或取代苯胺 - 芳香族杂单环化合物 - 氮杂环 - 苯基化合物 - 羧酰胺基 - 羧酸衍生物 - 二烷基芳基胺 - 杂芳香族化合物 - 烃衍生物 - 氟氯烃 - 咪唑内酰胺 - 单环苯基基团 - N-芳基哌嗪 - 有机硝基化合物 - 有机氧化物 - 有机氧化合物 - 有机磺酰胺 - 有机磺酸或其衍生物 - 有机氮化合物 - 有机氧化合物 - 有机硫酰胺 - 有机磺酸或其衍生物 - 有机硫化合物 - 苯基哌嗪 - 醛基胺 - 嘧啶 - 嘧啶-5-羧酸或其衍生物 - 嘧啶甲酰胺 - 二级脂肪族/芳香族胺 - 醛基 - 磺酰基 - 三芳基胺 - 乙烯酰胺 |
| 描述(Description) | 该化合物属于苯基哌嗪类有机化合物。这类化合物具有苯基哌嗪骨架,即哌嗪环与苯基相连的结构。 |
| 外部描述符(External Descriptors) | 暂无 |
| IC50 | JAK3, IC50: 8 nM |
|---|---|
| ALogP | 1.862 |
| hba_count | 5 |
| HBD Count | 3 |
| Rotatable Bond | 8 |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|